COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Quantum Genomics annonce avoir obtenu l'approbation de l'Assemblée Générale des Actionnaires sur la réduction de son capital social et sur l'apport en nature de 100% des titres d'ExactCure.
La Société Quantum Genomics annonce le rapprochement avec Exactcure, approuvé par les actionnaires lors de l'Assemblée Générale. Réduction du capital social et apport de 100% des titres effectués -
COMMUNIQUÉ DE PRESSE
Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.
Quantum Genomics successfully approved transactions of reducing share capital and acquiring Exactcure's shares during Shareholders' General Meeting. Company now holds 100% of Exactcure, reinforcing market position -
COMMUNIQUÉ DE PRESSE
GBI Group starts building construction work for new SMARTments connect in Bielefeld - Innovative accommodation offer with 223 units in a prime location directly at the central railway station
GBI Group commences building new SMARTments connect with 223 units in Bielefeld, offering innovative accommodation options at prime location near central railway station -
-
COMMUNIQUÉ DE PRESSE
DATAGROUP Reorganizes Management Board and Top Management Structure for the Next Stage of Growth
DATAGROUP reorganizes Management Board and top management structure for next growth stage. CFO Oliver Thome to leave, CEO Andreas Baresel to take over. Expansion of divisional board level planned -
COMMUNIQUÉ DE PRESSE
Baader Bank reports excellent results in first quarter of 2024
Baader Bank announces excellent first quarter 2024 results with earnings before tax of EUR 9.9 million and a consolidated return on equity after tax of 10.4%. Total revenue reached EUR 62.2 million driven by income improvements -
COMMUNIQUÉ DE PRESSE
Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
Drägerwerk AG & Co. KGaA reports solid business performance in Q1 2024 with order intake slightly above prior year, net sales and earnings below due to base effects. Annual forecast confirmed -
